Results 121 to 130 of about 20,777 (183)

Estrategias de potenciación y TEC en la depresión geriátrica

Confirmar el diagnóstico y evaluar la presencia de comorbilidades cuando los antidepresivos no son eficaces, descartando condiciones como la apnea del sueño no tratada.
Lauren B. Gerlach
core   +1 more source

Efficacy and safety of bupropion in quality of life of cancer patients, a randomized double blind placebo controlled clinical trial

Journal of Mazandaran University of Medical Sciences, 2019
Background and purpose: Decreasing the quality of life in cancer patients is an essential factor that influences their lives during the process of treatment and after that.
Saeid Azimi, Ebrahim Salehifar, Ghasem Janbabai, Ehsan zaboli, Narjes Hendouei, Fatemeh Saghafi, Samaneh Borhani   +6 more
doaj  

Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives

Patient Preference and Adherence, 2016
Cenk Tek Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA Abstract: Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain.
Tek C
doaj  

Efficacy of bupropion and cognitive behavioral therapy in the treatment of methamphetamine use disorder: a systematic review and meta-analysis

La investigación tiene por objetivo evaluar la eficacia de la terapia cognitivo-conductual y el bupropión en comparación con la terapia cognitivo-conductual sola para el trastorno por consumo de metanfetamina.
Bernabé Barreto, Marie Antouannet, Hurtado Merino, Luis Alejandro, Maya Apuy, Luis Fernando   +2 more
core   +1 more source

The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition?

Basic and Clinical Neuroscience, 2019
Introduction: Antidepressants can modulate brain monoamines by acting on pre-synaptic and postsynaptic receptors. Autoreceptors can reduce the monoamines effect on the somatodendritic or pre-synaptic regions despite its postsynaptic counter effects.
Shirin Sadighparvar, Fereshteh Tale, Parviz Shahabi, Somayyeh Naderi, Firouz Ghaderi Pakdel   +4 more
doaj  

Algoritmo de tratamiento para el TDAH en adultos

Las anfetaminas pueden ser ligeramente preferidas sobre el metilfenidato en adultos con TDAH, pero presentan un mayor riesgo de eventos adversos. En el TDAH con trastorno por uso de sustancias, considere no estimulantes como la atomoxetina o el bupropión
Mercedes Guaia Memita Guaia
core   +1 more source

A Meta-Analysis of the Efficacy of Bupropion Sustained-Release for Smoking Cessation in Heavy Smokers

Impulse: The Premier Undergraduate Neuroscience Journal, 2017
Cigarette smoking damages just about every organ in the body and reduces overall health. Even with the prevalence of accessible nicotine replacement therapies and behavioral counseling, there remains a need for alternative therapies to improve the odds ...
Adrian Paszek
doaj  

Patient-Level Determinants Outweigh Pharmacotherapy Choice in Smoking Cessation: Evidence from a Real-World Study in Turkey. [PDF]

Healthcare (Basel)
Mutlu HH, Erdem F, Mutlu HH.
europepmc   +1 more source

¿Aumentan los antidepresivos el riesgo de caídas en adultos mayores?

Los antidepresivos podrían reducir el riesgo de caídas en adultos mayores; el bupropión muestra la mayor reducción en comparación con la ausencia de tratamiento.
Scott R. Beach
core   +1 more source

Life-Threatening Bupropion Poisoning Successfully Treated by Intravenous Lipid Emulsion. [PDF]

Case Rep Crit Care
Della Casa FC, Haufroid V, Delongie K, Coppens T, Ponzetto E, De Schryver N.   +5 more
europepmc   +1 more source